Close
Novotech
Jabsco PureFlo 21 Single Use

Nippon Express opens pharma logistics centre in US

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Gilead Advances ADC Pipeline Expansion with $3B Tubulis Deal

Gilead Sciences has agreed to acquire Germany-based Tubulis in...

Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition

Neurocrine Biosciences is close to securing a more than...

Biogen to Acquire Apellis for $5.6 Billion in Major Deal

Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc....
- Advertisement -

MD Logistics, LLC, a group company of Japan-based Nippon Express Holdings, has opened Garner 2000 Pharmaceutical Logistics Centre, a dedicated pharmaceutical warehouse established in Garner, North Carolina in January this year.

North Carolina is a key hub for the pharmaceutical industry in the United States (US), with numerous major pharmaceutical manufacturers and life science companies having expanded into the state. It is also home to many research institutes and universities that have amassed significant medical knowledge and technologies.

The Nippon Express Group has positioned the pharmaceutical industry as a key industry in its ‘Nippon Express Group Business Plan 2023 — Dynamic Growth’, and is pursuing the global development of a safe and secure pharmaceutical logistics platform to meet increasingly sophisticated and diverse pharmaceutical logistics needs.

MD has four warehouses in Indiana and one in Nevada, and has located its sixth US warehouse in North Carolina, where pharmaceutical logistics needs are high and expected to grow further.

The Nippon Express Group will continue supporting customers in the pharmaceutical industry worldwide by building a reliable and secure global pharmaceutical logistics platform, aiming to contribute to the health of people around the world.

Latest stories

Related stories

Gilead Advances ADC Pipeline Expansion with $3B Tubulis Deal

Gilead Sciences has agreed to acquire Germany-based Tubulis in...

Neurocrine Nears $2.5bn Soleno Therapeutics Acquisition

Neurocrine Biosciences is close to securing a more than...

Biogen to Acquire Apellis for $5.6 Billion in Major Deal

Biogen Inc. has agreed to acquire Apellis Pharmaceuticals Inc....

Trump Announces 100% US Pharma Tariffs for Patented Drugs

The US pharma tariffs policy has been formalised through...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »